LU80001A1 - Verfahren zur herstellung von neuen imidazo-isochinolindionen - Google Patents

Verfahren zur herstellung von neuen imidazo-isochinolindionen

Info

Publication number
LU80001A1
LU80001A1 LU80001A LU80001A LU80001A1 LU 80001 A1 LU80001 A1 LU 80001A1 LU 80001 A LU80001 A LU 80001A LU 80001 A LU80001 A LU 80001A LU 80001 A1 LU80001 A1 LU 80001A1
Authority
LU
Luxembourg
Prior art keywords
isochinolindions
preparation
new imidazo
imidazo
new
Prior art date
Application number
LU80001A
Other languages
English (en)
Inventor
C Lillie
E Kutter
W Haarmann
V Austel
W Diederen
W Eberlein
J Heider
W Kobinger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2732906A external-priority patent/DE2732906C2/de
Priority claimed from DE19772732951 external-priority patent/DE2732951A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of LU80001A1 publication Critical patent/LU80001A1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU80001A 1977-07-21 1978-07-19 Verfahren zur herstellung von neuen imidazo-isochinolindionen LU80001A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2732906A DE2732906C2 (de) 1977-07-21 1977-07-21 In 5-Stellung durch einen Aminoalkylrest substituierte Imidazo-isochinolin-dione, Verfahren zu ihrer Herstellung und Arzneimittel
DE19772732951 DE2732951A1 (de) 1977-07-21 1977-07-21 Neue imidazo-isochinolin-dione

Publications (1)

Publication Number Publication Date
LU80001A1 true LU80001A1 (de) 1979-09-06

Family

ID=25772367

Family Applications (1)

Application Number Title Priority Date Filing Date
LU80001A LU80001A1 (de) 1977-07-21 1978-07-19 Verfahren zur herstellung von neuen imidazo-isochinolindionen

Country Status (29)

Country Link
US (1) US4176184A (de)
JP (1) JPS5422400A (de)
AT (1) AT366383B (de)
AU (1) AU519769B2 (de)
BG (1) BG30021A3 (de)
CA (1) CA1091232A (de)
CH (1) CH642367A5 (de)
CS (1) CS204032B2 (de)
DD (1) DD137933A5 (de)
DK (1) DK323378A (de)
ES (4) ES471254A1 (de)
FI (1) FI64371C (de)
FR (1) FR2398069A1 (de)
GB (1) GB2002751B (de)
GR (1) GR65025B (de)
HK (1) HK20685A (de)
HU (1) HU181000B (de)
IL (1) IL55168A (de)
IT (1) IT1107653B (de)
LU (1) LU80001A1 (de)
NL (1) NL7807760A (de)
NO (1) NO149314C (de)
NZ (1) NZ187916A (de)
PL (1) PL110398B1 (de)
PT (1) PT68329A (de)
SE (1) SE441746B (de)
SG (1) SG185G (de)
SU (1) SU688129A3 (de)
YU (1) YU40340B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP2558707Y2 (ja) * 1986-06-25 1998-01-14 松下電工 株式会社 蓄積式防排煙受信機
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
DE19918211A1 (de) 1999-04-22 2000-10-26 Basf Ag Cycloalkylsubstituierte Benzimidazole, deren Herstellung und Anwendung
WO2001025238A2 (en) * 1999-10-06 2001-04-12 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
US6506769B2 (en) * 1999-10-06 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
ES2299501T3 (es) 2000-08-11 2008-06-01 Boehringer Ingelheim Pharmaceuticals Inc. Compuestos heterociclicos utiles como inhibidores de tirosina-quinasas.
WO2005042530A1 (en) * 2003-10-30 2005-05-12 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368009B (de) * 1971-09-16 1974-06-17 Kabi Ab
US3919238A (en) * 1973-06-06 1975-11-11 Morton Norwich Products Inc 9-(Substituted amino)imidazo(4,5-f) quinolines
US3878206A (en) * 1973-06-06 1975-04-15 Morton Norwich Products Inc 9-(Substituted amino)imidazo{8 4,5-f{9 quinolines

Also Published As

Publication number Publication date
HK20685A (en) 1985-03-29
AU519769B2 (en) 1981-12-24
PL110398B1 (en) 1980-07-31
ES476168A1 (es) 1979-05-16
FR2398069B1 (de) 1981-05-22
SE7808018L (sv) 1979-01-22
GR65025B (en) 1980-06-16
PL208543A1 (pl) 1979-05-21
ATA498878A (de) 1981-08-15
YU40340B (en) 1985-12-31
GB2002751B (en) 1982-02-10
AT366383B (de) 1982-04-13
IT7850337A0 (it) 1978-07-17
SG185G (en) 1985-06-14
DD137933A5 (de) 1979-10-03
YU174778A (en) 1983-02-28
CS204032B2 (en) 1981-03-31
ES476166A1 (es) 1979-06-01
GB2002751A (en) 1979-02-28
BG30021A3 (en) 1981-03-16
ES476167A1 (es) 1979-04-16
JPS6112912B2 (de) 1986-04-10
CH642367A5 (de) 1984-04-13
FI64371C (fi) 1983-11-10
FI64371B (fi) 1983-07-29
FR2398069A1 (fr) 1979-02-16
US4176184A (en) 1979-11-27
IL55168A0 (en) 1978-09-29
AU3821078A (en) 1980-01-24
IL55168A (en) 1981-09-13
ES471254A1 (es) 1979-10-01
NL7807760A (nl) 1979-01-23
NO149314B (no) 1983-12-19
CA1091232A (en) 1980-12-09
HU181000B (en) 1983-05-30
PT68329A (de) 1978-08-01
IT1107653B (it) 1985-11-25
FI782011A (fi) 1979-01-22
JPS5422400A (en) 1979-02-20
SU688129A3 (ru) 1979-09-25
NO149314C (no) 1984-03-28
DK323378A (da) 1979-01-22
NO782498L (no) 1979-01-23
SE441746B (sv) 1985-11-04
NZ187916A (en) 1981-05-01

Similar Documents

Publication Publication Date Title
DD132663A5 (de) Verfahren zur herstellung von neuen penicillansaeurederivaten
DD133803A1 (de) Verfahren zur herstellung von furokumarinen
ATA162876A (de) Verfahren zur herstellung von neuen piperazinyliminorifamycinen
AT350748B (de) Verfahren zur herstellung von neuen d-17alpha- aethinyl-17beta-acyloxy-19-nortestosteron-3- oximen
DD134088A5 (de) Verfahren zur herstellung von neuen pyrrolidinderivaten
DD134090A5 (de) Verfahren zur herstellung von pyridinylaminoalkylaether
ATA292078A (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
DD135283A5 (de) Verfahren zur herstellung von neuen aminoalkoxyphenyl-derivaten
ATA392577A (de) Verfahren zur herstellung von acylcyaniden
LU80001A1 (de) Verfahren zur herstellung von neuen imidazo-isochinolindionen
DD136832A5 (de) Verfahren zur herstellung von 1,2-dichloraethan
AT353286B (de) Verfahren zur herstellung von neuen 9- -hydroxyaethoxymethylguaninderivaten
DD130144A5 (de) Verfahren zur herstellung von benzoylcyanid
ATA392477A (de) Verfahren zur herstellung von acylcyaniden
PT68989A (de) Verfahren zur herstellung von neuen arylaminoimidazolinderivaten
DD134100A5 (de) Verfahren zur herstellung von lactamen
DD139252A5 (de) Verfahren zur herstellung von alkylphenolen
LU78483A1 (de) Verfahren zur herstellung von benzoxazolyl-phenylstilbenen
DD135384A5 (de) Verfahren zur herstellung von 2-hydroxybenzthiazol-verbindungen
AT352696B (de) Verfahren zur herstellung von cyclohexandion- (1,4)-tetramethyldiketal
LU79271A1 (de) Verfahren zur herstellung von neuen derivaten des 9-fluorprednisolons
AT354442B (de) Verfahren zur herstellung von neuen 1- thiazolyl-imidazolidinonen
AT354441B (de) Verfahren zur herstellung von neuen 1- benzthiazolyl-imidazolidinonen
AT352697B (de) Verfahren zur herstellung von neuen cyclohexen- (1)-dion-(3,6)-tetraalkyldiketalen
DD135382A5 (de) Verfahren zur herstellung von triazolo-thieno-diazepin-1-onen